Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer

By Yamada Yasuhide  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1690-1696

Springer Publishing Company

Access to resources Recommend Favorite

Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer

By Satoh Taroh  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1511-1518

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

By Wakelee Heather   Fisher George  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 241-242

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

By Hoff Paulo   Saad Everardo   Pazdur Richard   Wolff Robert   Lassere Yvonne   Bogaard Karla   Abbruzzese James  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite